Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Chinese Traditional and Herbal Drugs ; (24): 2097-2102, 2018.
Article in Chinese | WPRIM | ID: wpr-852005

ABSTRACT

Objective To investigate the effect of Reduning Injection on Vero cells and suckling mice infected by EV71 virus and its mechanism in vitro and in vivo. Methods The anti-virus ability was exhibited in Vero cells which were infected by 33 TCID50 and 25 TCID50 titers of EV71 in vitro. Meanwhile, the antiviral activity in vivo was evaluated on suckling mice model, in which suckling mice were intraperitoneal injected with EV71 at 100 μL. After 2 h infection, Reduning Injection 2.60, 1.30, and 0.65 g/kg and ribavirin 10 mg/kg were followed for treatment. To further understand the antiviral effects of Reduning Injection, weigh of suckling mice, clinical symptoms, expression of IL-1β, IL-6, MCP-1, and TNF-α in skeletal muscle were recorded. Moreover, histological examination of skeletal muscle was examined. Results The results demonstrated that Reduning Injection 5.0 mg/mL could obviously inhibit Vero cells lesion induced by EV71 in vitro. Compared with the model group, suckling mouse model results showed the high and middle dose of Reduning Injection could reduce clinical manifestations scores, increase the weight and improve living conditions of model mice, decrease the expression of IL-1β, IL-6, TNF-α, and MCP-1 in skeletal muscle of suckling mice (P<0.05, 0.01). Histological damages in skeletal muscle were also alleviated with Reduning Injection treatment. Conclusion In a suckling mouse model, Reduning Injection can reduce mortality and obviously prolong the survival time of suckling mice caused by EV71 infection. It can alleviate clinical symptoms and growth inhibition caused by the EV71 virus. Inhibition of IL-1β, IL-6, TNF-α, and MCP-1 levels may be the important mechanism of Reduning Injection in the treatment of hand-foot-and-mouth disease.

2.
China Journal of Chinese Materia Medica ; (24): 4598-4604, 2016.
Article in Chinese | WPRIM | ID: wpr-231015

ABSTRACT

To evaluate the rationality of alcohol precipitation technology of Biqiu granule by investigating its effect on serum histamine, IgE, IL-4, IFN and TNF-α. The contents of cafferic acid and rosmarinic acid were used as the evaluation indexes, and some factors affecting index were firstly evaluated by Plackett-Burman design; then alcohol precipitation technology was further optimized by Box-Behnken design to determine the optimal alcohol precipitation conditions. The best alcohol precipitation conditions were as follows: the relative density of herb liquor was 1.15 (65 ℃); the concentration of alcohol was 70%, and standing time was 12 hours. Optimal alcohol precipitation technology of Biqiu granules determined by pharmacodynamic screening, Plackett-Burman and Box-Behnken design tests, was stable and feasible with good predictability, providing reliable basis for the industrialization production of Biqiu granules.

3.
Chinese Journal of Natural Medicines (English Ed.) ; (6): 881-888, 2015.
Article in English | WPRIM | ID: wpr-812468

ABSTRACT

The present study was designed to evaluate the protective effects of Reduning injection against Enterovirus 71 (EV71) in Vero cells and in mice. The Vero cells were infected with 100 and 50 TCID50 (50% tissue culture infective dose) of EV71, respectively. The inhibition of Reduning injection on cytopathic effect (CPE) was detected. Meanwhile, a mouse model produced by intraperitoneal EV71-infection (10(6) TCID50), was used to investigate the protective effects of Reduning injection. The total survival rate, living time, daily survival rate, weight ratio, and score for symptoms were examined. The viral loads in Vero cells and muscle tissues were detected using real-time PCR. Finally, the content of cytokines was analyzed by ELISA. In the Vero cells, 2.5 mg crude drug·mL(-1) of Reduning injection inhibited CPE induced by EV71 infection. In the mice, 1.3 g crude drug·kg(-1) of Reduning injection rescued death triggered by infection, in comparison with model group. Moreover, the survival rate, weight ratio, and clinical scores were also improved. The viral RNA copies in the Vero cells and the mice muscle tissues were reduced. Besides, the steep EV71-induced accumulations of TNF-α and MCP-1 were decreased by Reduning injection. In conclusion, Reduning injection showed promising protective effects against EV71 in Vero cells and in mice.


Subject(s)
Animals , Humans , Male , Mice , Antiviral Agents , Chlorocebus aethiops , Drugs, Chinese Herbal , Enterovirus A, Human , Physiology , Enterovirus Infections , Drug Therapy , Genetics , Metabolism , Virology , Mice, Inbred ICR , Tumor Necrosis Factor-alpha , Genetics , Metabolism , Vero Cells , Virus Replication
4.
Chinese Traditional and Herbal Drugs ; (24): 236-239, 2015.
Article in Chinese | WPRIM | ID: wpr-854335

ABSTRACT

Objective: To investigate the effect and mechanism of Reduning Injection on the rats with acute lung injury (ALI) induced by lipopolysaccharide (LPS) from cytokine storm. Methods: The model of ALI was established by instilling LPS (6 mg/kg) to SD rats. The effects of iv administration of Reduning Injection with three doses (10.16, 5.08, and 2.54 g/kg) and control drug Dexamethasone (0.5 mg/kg) on IL-1β, TNF-α, IL-4, IL-6, IL-8, IL-10, ICAM-1, and NF-KB in lung homogenate and lung tissue pathology were observed. Results: Reduning Injection could reduce the levels of IL-1β, TNF-α, IL-4, IL-6, IL-8, IL-10, ICAM-1, and NF-KB in lung tissue of rats, and improve the morphologic changes of lung tissue. Conclusion: Reduning Injection could improve the pathological changes of lung tissue, and the important curative mechanism may be reducing the production and release of inflammatory mediators in ALI process induced by LPS.

5.
China Journal of Chinese Materia Medica ; (24): 4139-4142, 2014.
Article in Chinese | WPRIM | ID: wpr-310928

ABSTRACT

<p><b>OBJECTIVE</b>To research the effects of Guizhi Fuling capsule on sex hormones levels in blood serum and breast issue morphology of hyperplasia of mammary glands model rats.</p><p><b>METHOD</b>The unpregnancy SD rat models of hyperplasia of mammary glands were established by injecting 0.5 mg x kg(-1) benzoate estradiol. After five weeks doses,the effects of Guizhi Fuling capsule 2.0, 1.0, 0.5 g x kg(-1) and Rupixiao tablet 0.5 g x kg(-1) on the changes of papilla diameter, height and breast issue morphology of the naimal models were explored, and sex hormones levels in blood serum were measured.</p><p><b>RESULT</b>Guizhi Fuling capsule can inhibitnipple swell, improve breast tissue morphology pathological profiles of the animal models, and decrease oestradiol (E2) level and increase progesterone (P) level in blood serum.</p><p><b>CONCLUSION</b>These results suggested that Guizhi Fuling capsule could, improve mammary gland pathological profiles. Regulating sex hormone levels may be its important mechanism for treatment of hyperplasia of mammary glands.</p>


Subject(s)
Animals , Female , Rats , Capsules , Drugs, Chinese Herbal , Pharmacology , Gonadal Steroid Hormones , Blood , Hyperplasia , Mammary Glands, Animal , Pathology
6.
Chinese Journal of Oncology ; (12): 748-752, 2012.
Article in Chinese | WPRIM | ID: wpr-307301

ABSTRACT

<p><b>OBJECTIVE</b>To clarify the expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) mRNA in hepatocellular carcinoma (HCC).</p><p><b>METHODS</b>The expression and distribution of MACC1 were assessed by quantitative real-time polymerase chain reaction (RT-PCR) and immunohistochemical staining (IHC) in a cohort of hepatitis B virus-related HCC, including 138 in early (A), 96 in intermediate (B) and 120 in advanced stages (C). The association of MACC1 mRNA with disease progression and outcomes was analyzed by univariate and multivariate Cox analysis.</p><p><b>RESULTS</b>The intratumoral expressions of MACC1 mRNA in HCC stage I (0.001 76, range: 0.000 54 - 0.002 47), stage II (0.002 49, range: 0.000 55 - 0.006 78) and stage III (0.008 35, range: 0.006 86 - 0.009 88) were about 3-, 4- and 14-fold higher than that in the normal liver tissue (0.000 59, range: 0.000 57 - 0.000 60), respectively. Intratumoral expression of MACC1 mRNA increased with disease progression from stage I to stage III. HCC clinical staging classification, age, portal vein invasion and tumor differentiation were significantly associated with intratumoral high expression of MACC1 mRNA (All P < 0.05). Immunohistochemical staining showed that there was an increased MACC1 expression in cytoplasm of HCC cells and positive nuclear staining in some cases. Increased MACC1 mRNA expression could predict poor outcome and recurrence in stage A and B HCC postoperatively. The median tumor-free survival and total survival of patients with high MACC1 mRNA expression were 34.0 and 40 months, respectively, significantly lower than that in those with low expression (48.0 and 48.0 months) (all P < 0.01). Cox analysis showed that Child-Pugh grading and high expression of MACC1 mRNA were independent predictive factors, and high expression of MACC1 was an independent predictive factor affecting the tumor-free survival.</p><p><b>CONCLUSIONS</b>MACC1 mRNA up-regulation is a feature of disease progression in HCC. MACC1 mRNA expression in the HCC may become an independent predictive factor for recurrence and survival in postoperative HCC patients.</p>


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult , Carcinoma, Hepatocellular , Metabolism , Pathology , Virology , DNA, Viral , Disease-Free Survival , Follow-Up Studies , Hepatitis B virus , Liver Neoplasms , Metabolism , Pathology , Virology , Neoplasm Recurrence, Local , Neoplasm Staging , Proportional Hazards Models , RNA, Messenger , Metabolism , Real-Time Polymerase Chain Reaction , Survival Rate , Transcription Factors , Genetics , Metabolism , Up-Regulation
7.
Chinese Journal of Hepatology ; (12): 759-763, 2011.
Article in Chinese | WPRIM | ID: wpr-239332

ABSTRACT

<p><b>OBJECTIVES</b>Investigate the clinical efficacy of cryotherapy ablation treatment for advanced hepatocellular carcinoma. analyse the predictive factors of cryotherapy ablation treatment.</p><p><b>METHODS</b>There were 190 cases of hepatitis B-related HCC patients with advanced HCC from 2005 to 2008 in our hospital. By using clinical cohort method, they included cryoablation group (147 cases) and control group (43 cases), The median survival time and time to disease progression were compared. Evaluate clinical significance of age, gender, location of portal vein tumor thrombus, HBeAg, tumor histological grade, Child-Pugh classification, end-stage liver disease (MELD) score, advanced liver cancer prediction system (ALCPS) score and the Eastern Cooperative Oncology Group performance status (ECOG PS) score for predicting the efficacy of cryoablation. Group rates were compared with the x2 test, survival analysis by using Kaplan-Meier method, survival rates were compared by Log-rank analysis; multiple factor survival analysis by using Cox regression model.</p><p><b>RESULTS</b>Median survival time of cryoablation group and Control group was 7.5 (4.2 to 14.6) months and 3.2 (1.2 to 8.6) months, median TTP was 3.5 (2.5 to 4.5) months and 1.5 (1.0 to 3.5 months), the differences were statistically significant ( P less than 0.05 ). Median OS and TTP of advanced HCC patients who had Well-differentiated tumor, Child-pugh A-class and low score of MELD score, ALCPS score, ECOG PS score were significantly longer than the poorly differentiate, Child-Pugh B-class and the high those scores ( P less than 0.05). ECOG PS ( P less than 0.05, 95% CI 1.074 to 2.143) and ALCPS (P less than 0.05, 95% CI 1.005 to 2.121) were independent predictors for OS of advanced HCC.</p><p><b>CONCLUSION</b>Cryoablation treatment can prolong median OS and TTP of advanced HCC; ECOG PS and ALCPS are important predictors for survival time of advanced HCC.</p>


Subject(s)
Female , Humans , Male , Middle Aged , Carcinoma, Hepatocellular , General Surgery , Cryosurgery , Liver Neoplasms , General Surgery , Prognosis , Proportional Hazards Models , Survival Rate , Treatment Outcome
8.
Chinese Journal of Experimental and Clinical Virology ; (6): 377-379, 2007.
Article in Chinese | WPRIM | ID: wpr-248747

ABSTRACT

<p><b>OBJECTIVE</b>To study the clinical feature and more reasonable diagnostic typing criteria for patients with liver failure.</p><p><b>METHODS</b>13/21 cases of ALF, SALF with no past liver disease, 49/72 cases of with chronic hepatitis, and 23/73 cases ALF, SALF with liver cirrhosis, were analyzed respectively.</p><p><b>RESULTS</b>1 ALF patients (1). There exist significant statistic differences in ALB, ALT, CHE in three ALF groups.(2). It had statistic differences in those patients with hepatic encephalopathy.(3). The prognosis of the patients with chronic hepatitis group (42.85 percent) was best than that of chronic cirrhosis (26.09 percent) and no past liver disease (15.38 percent). (2) In SALF patients (1). There exist significant statistic differences in ALB, GLO, ALT, AST, BDIL, GLU and CHE in three SALF groups.(2). It had statistic differences in those patients with hepatic encephalopathy in three SALF groups.(3). The prognosis of the patients with chronic hepatitis group (51.39 percent) was best than that of chronic cirrhosis (36.85 percent) and no past liver disease (33.33 percent).</p><p><b>CONCLUSION</b>There are different clinic feature and prognosis in three ALF or SALF groups, so we suggest that it were clinic practicability and science in classify of liver failure at present.</p>


Subject(s)
Humans , Liver Failure , Classification , Liver Failure, Acute , Classification , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL